The elucidation of placental origins of pregnancy disorders.
Not Applicable
Recruiting
- Conditions
- Fetal growth restriction and hypertensive pregnancy disorders
- Registration Number
- JPRN-UMIN000028772
- Lead Sponsor
- Mie university hospital, Department of Obstetrics and Gynecology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
1. Age>=20
2. Gestational age between 20 + 0 and 33 + 6 weeks in pregnant women.
3. The expected date of confinement is determined using the criteria of the guidelines for obstetrical practice in Japan (2014) in pregnant women.
4. Singleton pregnancy.
5. Written informed consent.
Exclusion Criteria
Attending physician decides to entry inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways in placental development contribute to fetal growth restriction and preeclampsia in observational studies?
How does placental dysfunction identified in JPRN-UMIN000028772 compare to standard-of-care biomarkers for predicting hypertensive pregnancy disorders?
What placental-derived biomarkers are associated with early detection of fetal growth restriction and preeclampsia in JPRN-UMIN000028772?
What adverse outcomes are linked to placental insufficiency in JPRN-UMIN000028772 and how are they managed in clinical practice?
What therapeutic strategies targeting placental angiogenesis are being explored for hypertensive pregnancy disorders and fetal growth restriction?